FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes

Steven J. Sherry, Abdel K. Tahari, Sahar Mirpour, Andrew Colucci, Rathan M. Subramaniam

Research output: Contribution to journalArticle

Abstract

Paraneoplastic neurologic syndromes (PNS) are a rare, heterogeneous group of complications associated with malignancy, unrelated to direct tumor invasion or metastasis, that may be immune-mediated. The aim of this article is to provide an overview of PNS and outline the value of 2-deoxy-2-[ 18F]fluoro-D-glucose PET/CT in the evaluation of patients with a PNS. 2-deoxy-2-18F-fluoro-D-glucose PET/CT is valuable to identify or exclude an occult malignancy in patients with suspected paraneoplastic syndromes.

Original languageEnglish (US)
Pages (from-to)117-126
Number of pages10
JournalImaging in Medicine
Volume6
Issue number1
DOIs
StatePublished - Feb 2014

Fingerprint

Nervous System Paraneoplastic Syndromes
Fluorodeoxyglucose F18
Paraneoplastic Syndromes
Neoplasms
Neoplasm Metastasis

Keywords

  • occult malignancy
  • paraneoplastic syndromes
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Sherry, S. J., Tahari, A. K., Mirpour, S., Colucci, A., & Subramaniam, R. M. (2014). FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes. Imaging in Medicine, 6(1), 117-126. https://doi.org/10.2217/iim.13.73

FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes. / Sherry, Steven J.; Tahari, Abdel K.; Mirpour, Sahar; Colucci, Andrew; Subramaniam, Rathan M.

In: Imaging in Medicine, Vol. 6, No. 1, 02.2014, p. 117-126.

Research output: Contribution to journalArticle

Sherry, SJ, Tahari, AK, Mirpour, S, Colucci, A & Subramaniam, RM 2014, 'FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes', Imaging in Medicine, vol. 6, no. 1, pp. 117-126. https://doi.org/10.2217/iim.13.73
Sherry, Steven J. ; Tahari, Abdel K. ; Mirpour, Sahar ; Colucci, Andrew ; Subramaniam, Rathan M. / FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes. In: Imaging in Medicine. 2014 ; Vol. 6, No. 1. pp. 117-126.
@article{d3c2726652ad40d68e6587f66932cb94,
title = "FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes",
abstract = "Paraneoplastic neurologic syndromes (PNS) are a rare, heterogeneous group of complications associated with malignancy, unrelated to direct tumor invasion or metastasis, that may be immune-mediated. The aim of this article is to provide an overview of PNS and outline the value of 2-deoxy-2-[ 18F]fluoro-D-glucose PET/CT in the evaluation of patients with a PNS. 2-deoxy-2-18F-fluoro-D-glucose PET/CT is valuable to identify or exclude an occult malignancy in patients with suspected paraneoplastic syndromes.",
keywords = "occult malignancy, paraneoplastic syndromes, PET/CT",
author = "Sherry, {Steven J.} and Tahari, {Abdel K.} and Sahar Mirpour and Andrew Colucci and Subramaniam, {Rathan M.}",
year = "2014",
month = "2",
doi = "10.2217/iim.13.73",
language = "English (US)",
volume = "6",
pages = "117--126",
journal = "Imaging in Medicine",
issn = "1755-5191",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes

AU - Sherry, Steven J.

AU - Tahari, Abdel K.

AU - Mirpour, Sahar

AU - Colucci, Andrew

AU - Subramaniam, Rathan M.

PY - 2014/2

Y1 - 2014/2

N2 - Paraneoplastic neurologic syndromes (PNS) are a rare, heterogeneous group of complications associated with malignancy, unrelated to direct tumor invasion or metastasis, that may be immune-mediated. The aim of this article is to provide an overview of PNS and outline the value of 2-deoxy-2-[ 18F]fluoro-D-glucose PET/CT in the evaluation of patients with a PNS. 2-deoxy-2-18F-fluoro-D-glucose PET/CT is valuable to identify or exclude an occult malignancy in patients with suspected paraneoplastic syndromes.

AB - Paraneoplastic neurologic syndromes (PNS) are a rare, heterogeneous group of complications associated with malignancy, unrelated to direct tumor invasion or metastasis, that may be immune-mediated. The aim of this article is to provide an overview of PNS and outline the value of 2-deoxy-2-[ 18F]fluoro-D-glucose PET/CT in the evaluation of patients with a PNS. 2-deoxy-2-18F-fluoro-D-glucose PET/CT is valuable to identify or exclude an occult malignancy in patients with suspected paraneoplastic syndromes.

KW - occult malignancy

KW - paraneoplastic syndromes

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=84896743010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896743010&partnerID=8YFLogxK

U2 - 10.2217/iim.13.73

DO - 10.2217/iim.13.73

M3 - Article

AN - SCOPUS:84896743010

VL - 6

SP - 117

EP - 126

JO - Imaging in Medicine

JF - Imaging in Medicine

SN - 1755-5191

IS - 1

ER -